Pulmonx Corporation (LUNG:NASDAQ) closed at $1.83 on October 23, 2026, down 2.66% on the day. The stock trades 36.7% below its 52-week high of $2.89 and 61.9% above its 52-week low of $1.13. Over the past year, it gained 11.6%. Pulmonx Corporation is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, LUNG closed higher on 113 days (45%). Its best day was August 3, 2026 (+30.06%) and its worst was November 13, 2025 (-18.88%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 3 times.
ProLung Inc is a medical technology company which has developed lung cancer risk test called as ProLung Test to assess the risk of malignancy in lung nodules found in the chest by a Computed Tomography (CT) scan.
Find more stocks like LUNG with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.